Market Insider

Take a look at some of the biggest movers in the premarket: AstraZeneca (AZN) – The drugmaker’s stock fell 2.9% in premarket trading after an independent monitoring board told U.S. health officials that the company may have given incomplete efficacy data from its Covid-19 vaccine trial. The Data Safety Monitoring Board said it wanted AstraZeneca
0 Comments
Take a look at some of the biggest movers in the premarket: AstraZeneca (AZN) – The drugmaker said a U.S. study showed its Covid-19 vaccine had 79% efficacy in preventing symptomatic illness, 100% effectiveness against critical disease and hospitalization, and did not pose a higher risk of blood clots. AstraZeneca shares gained 2.2% in premarket
0 Comments
A Five Below location. John Greim | LightRocket | Getty Images Check out the companies making headlines after the bell on Wednesday: Five Below – The discount retailer’s shares ticked up 6% after the company’s fourth-quarter results topped Wall Street analyst expectations. Five Below reported earnings per share of $2.20 on revenue of $859 million.
0 Comments
A Dollar General store in Creve Coeur, Illinois. Daniel Acker | Bloomberg | Getty Images Check out the companies making headlines in midday trading.  Williams-Sonoma – Shares of the retailer jumped more than 20% after the company beat top and bottom line estimates during the fourth quarter. Williams-Sonoma earned $3.95 per share excluding items during
0 Comments
Chairman of the Federal Reserve Jerome Powell testifies during the Senate’s Committee on Banking, Housing, and Urban Affairs hearing examining the quarterly CARES Act report to Congress on September 24, 2020, in Washington, DC. Drew Angerer | AFP | Getty Images Treasury yields flared on Thursday as bond market players grappled with the Federal Reserve’s
0 Comments
Chairman of the Federal Reserve Jerome Powell listens during a Senate Banking Committee hearing on “The Quarterly CARES Act Report to Congress” on Capitol Hill in Washington, U.S., December 1, 2020. Susan Walsh | Reuters The Federal Reserve could remain a source of angst for markets in the week ahead, with chairman Jerome Powell scheduled
0 Comments